The OTA's Executive comprises the Chief Executive Officer, the National Medical Director and the General Manager.
Chief Executive Officer
Ms Lucinda Barry
Lucinda Barry commenced as the Chief Executive Officer of the Organ and Tissue Authority (OTA) in September 2017. In addition to being responsible for the day to day operations of the OTA, Lucinda is also a member of the inaugural OTA Board.
Lucinda brings to the position extensive experience and knowledge in health care, both clinical and policy. In her exemplary career, she has held senior leadership roles within government, the public service and in health service management and delivery.
In her most recent positions as the Prime Minister’s Senior Adviser on health policy and Chief of Staff to the Assistant Health Minister, Lucinda is well informed on Australia’s organ and tissue donation program.
Lucinda brings a wealth of clinical and change management knowledge from her previous clinical positions as Trauma Coordinator at the Royal Melbourne Hospital, where she was integral to the implementation of the Victorian State Trauma System at both a state and hospital level. Lucinda has also been a frontline emergency specialist nurse and was the Director of Nursing at the National Capital Private Hospital in Canberra.
Lucinda has previously held executive positions within the health profession including Vice-President of the Australasian Trauma Society and the Emergency Nurses Association Victoria.
With an extensive network of stakeholders in the health sector, Lucinda has a keen appreciation and understanding of the importance of working in partnership and collaboration to deliver the best health outcomes for the community.
National Medical Director
Dr Helen Opdam
Dr Helen Opdam commenced as the National Medical Director of the Organ and Tissue Authority on 1 July 2014. She is a Senior Intensive Care Specialist at the Austin Hospital in Melbourne and Director of Warringal Private Hospital Intensive Care Unit. Her intensive care interests include improving patient care through enhancing hospital systems and neuro-intensive care.
Dr Opdam has a long standing commitment to organ and tissue donation, holding the position of the inaugural State Medical Director of DonateLife Victoria from 2009 to June 2015. In 1998 in Victoria Dr Opdam led the implementation of the routine review of hospital deaths with the aim of optimising identification of potential donors and ensuring the option for donation is discussed with patients' families. In 2002 she was appointed as a medical consultant to the Victorian Organ Donation Agency, providing medical suitability and other clinical advice on donation cases. She was on the National Institute of Clinical Studies (NICS) Advisory Committee that oversaw the National Organ Donation Collaborative (2006-2009).
Dr Opdam is a member of the Australian and New Zealand Intensive Care Society (ANZICS) Death and Organ Donation Working Party that has developed the ANZICS Statement on Death and Organ Donation. She regularly facilitates Medical ADAPT workshops to provide education to Intensive Care Specialists and trainees and other doctors on brain death and organ donation.
Dr Opdam is the Chair of the OTA Data and Audit Working Group, which oversees the national audit of deaths to detect potential organ donors. She contributes to numerous other committees and workings groups including being a Council member of the International Society for Organ Donation and Procurement, and on the NHMRC Expert Advisory Group for the development of ethical guidelines on the eligibility criteria and allocation protocols for organ transplantation from deceased donors. She is a regular invited speaker at national and international conferences.
Dr Opdam graduated from Monash University in 1990 with First Class Honours.
Ms Judy Harrison
Ms Judy Harrison has been Chief Financial Officer of the OTA since March 2010. She provides assurance on the OTA's financial sustainability, its control framework, and the accuracy of its appropriation bills, budget estimates and financial reporting. The Chief Financial Officer is the principal financial advisor to the OTA's CEO and executive team.
Ms Harrison was the Director of Financial Reporting and Treasury within the Department of Health, a role she held for five years. This role encompassed managing the department's treasury team and responsibility for both monthly and annual external reporting requirements.
Ms Harrison is a qualified accountant with significant previous financial reporting and financial management experience in both the public and private sectors, including five years consulting, five years in the United Kingdom banking sector, and audit experience gained in a major chartered accounting firm.